Novavax Announces COVID-19 Vaccine Clinical Development Progress
Go back to Novavax Announces COVID-19 Vaccine Clinical Development Progress| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 8.00 -0.14 (1.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.14 | 52 Week High | $9.23 | |||
| Open | $8.13 | 52 Week Low | $1.16 | |||
| Day High | $8.13 | P/E | N/A | |||
| Day Low | $7.92 | EPS | $-0.30 | |||
| Volume | 292,541 | |||||
| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 8.00 -0.14 (1.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.14 | 52 Week High | $9.23 | |||
| Open | $8.13 | 52 Week Low | $1.16 | |||
| Day High | $8.13 | P/E | N/A | |||
| Day Low | $7.92 | EPS | $-0.30 | |||
| Volume | 292,541 | |||||

